Protease inhibitors in HIV infection
BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7176.122 (Published 09 January 1999) Cite this as: BMJ 1999;318:122Lipodystrophy may be a consequence of prolonged survival
- Neil Buss, International medical director (neil.buss@roche.com),
- Frank Duff, Clinical director
- F Hoffmann-La Roche, CH-4070 Basle, Switzerland
- Roche Laboratories, Nutley, New Jersey, USA
- Department of Genitourinary Medicine, Charing Cross Hospital, London W6 8RF
EDITOR—Berger's article on HIV protease inhibitors and the putative increased risk of heart disease contains inaccuracies and could be unnecessarily alarming.1 Several recent reports describe one or more syndromes in HIV infected people known variously as buffalo hump, protease paunch, or lipodystrophy. 2 3 The symptoms include fat accumulation associated with increased abdominal girth or abnormal dorsal cervical fat coupled with wasting in extremities. Some reports have also highlighted hypertriglyceridaemia, hypercholesterolaemia, and insulin resistance.2
Case reports on small numbers of patients have suggested that these symptoms are associated with protease inhibitors. However, similar symptoms occur in some HIV positive patients not receiving protease inhibitors. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.